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ABSTRACT
Dysfunction of neural stem cells (NSCs) has been linked to fetal neuropathy, one of the most
devastating complications of gestational diabetes. Several studies have demonstrated that melatonin
(Mel) exerted neuroprotective actions in various stresses. However, the role of autophagy and the
involvement of Mel in NSCs in hyperglycemia (HG) have not yet been fully established. Here, we
found that HG increased autophagy and autophagic flux of NSCs as evidenced by increasing LC3B II/I
ratio, Beclin-1 expression, and autophagosomes. Moreover, Mel enhanced NSCs proliferation and
self-renewal in HG with decreasing autophagy and activated mTOR signaling. Consistently, inhibition
of autophagy by 3-Methyladenine (3-Ma) could assist Mel effects above, and induction of autophagy
by Rapamycin (Rapa) could diminish Mel effects. Remarkably, HG induced premature differentiation
of NSCs into neurons (Map2 positive cells) and astrocytes (GFAP positive cells). Furthermore, Mel
diminished HG-induced premature differentiation and assisted NSCs in HG differentiation as that in
normal condition. Coincidentally, inhibiting of NSCs autophagy by 3-Ma assisted Mel to modulate dif-
ferentiation. However, increasing NSCs autophagy by Rapa disturbed the Mel effects and retarded
NSCs differentiation. These findings suggested that Mel supplementation could contribute to mim-
icking normal NSCs proliferation and differentiation in fetal central nervous system by inhibiting
autophagy in the context of gestational diabetes. STEM CELLS 2019;37:504–515
SIGNIFICANCE STATEMENT
Neural stem cells play important roles in fetal neurodevelopment. The incidences of gestational
diabetes are rising in the world and prevention of fetal neuropathy in gestational diabetes melli-
tus (GDM) needs to be deeply explored. In addition, autophagy of NSCs in HG is still unclear.
Here, it is reported that HG inhibits proliferation and induces premature differentiation of NSCs
by promoting autophagy and autophagic flux. The naturally occurring hormone melatonin (Mel)
antagonized HG-mediated effects and maintained normal proliferation and differentiation in
NSCs by modulating autophagy, which protected NSCs mainly by downregulating Beclin-1 and
up modulating mTORC1 signaling. This work indicates that Mel could be used as a potential
drug to aid in fetal central nervous system (CNS) development in GDM patients.
INTRODUCTION
Gestational diabetes mellitus (GDM) accounts
for 3%–5% of all pregnancies [1]. GDM imposes
a substantial economic burden on both affected
patients and society in general because it is
highly related to malformations and maternal
health complications. Central nervous system
(CNS) development is especially vulnerable to
GDM [2]. Several studies on offspring of mothers
with GDM show higher rates of gross and fine
motor abnormalities [3], attention deficit hyper-
activity disorder [4], learning difficulties [4], and
autism spectrum disorder [5]. Neurodevelop-
ment disorders [6] or neural congenital malfor-
mations [7] have been found to be due to an
imbalance between proliferation and differenti-
ation of neural stem cells (NSCs).
The cellular process of autophagy has been
shown to play an important role in neural
development [8]. Inhibition of autophagy has
been directly linked to uncontrolled prolifera-
tion and excessive apoptosis in the develop-
ment of the nervous system [9]. Autophagy,
or “self-eating,” is related to mechanisms of
lysosome-dependent degradation of intracellular
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components during stress. Upon activation of autophagy, focal
degradation of cytoplasmic areas is sequestered by a membrane
structure, which is known as a phagophore. The phagophore
expands and matures into an intact double-membrane structure
termed an autophagosome. The engulfed materials are degraded
when autophagosomes fuse with lysosomes [10]. Autophagic
flux is the process of transitioning from phagophore to degrada-
tion of the contents. Several proteins, including microtubule-
associated protein light chain 3 B (LC3B), p62/SQSTM1, and
Beclin 1 have been implicated in the process of autophagy and
are used as markers for the activation of the process. LC3B is
the most widely used autophagic marker, and is located both
inner and outer membranes of autophagosomes. Autophagy
increases the conversion of LC3B I into LC3B II, which is
degraded through lysosomal turnover [10]. Beclin-1 is an autop-
hagy initiated protein. Accumulation of LC3B II is thus used as a
marker for autophagy. p62/SQSTM1 possesses LC3-interacting
region and serves as a signaling hub of autophagy. p62 is
degraded through the process of autophagy, therefore its degra-
dation can serve as a marker of autophagic clearance [11].
Increases in Beclin-1, an autophagy initiation protein, also
accompany activation of the process, and the protein has been
directly linked to neurogenesis. NSCs derived from Beclin-1
heterozygosis caused reduction of proliferating cells and differ-
entiating immature neurons [12]. Finally, the mechanistic tar-
get of rapamycin (mTOR) pathway is a chief regulator of
autophagy, which plays important role in proliferation and
differentiation of NSCs. Type I mTOR complex (mTORC1) have
different effects on stem cells differentiation at various levels.
During undifferentiated stages, mTORC1/p70S6K activity is main-
tained at lower levels. Once NSCs begin to differentiate, mTORC1/
p70S6K mediated protein translation increases [13]. Autop-
hagy function requires more research, especially in regard to
pathologies.
Clinical research has shown that high-risk pregnant women
(those with gestational diabetes and hypertension) also suffer
from poor quality sleep [14]. Ten genome-wide association
scans involving 36,610 Europeans showed that variants in the
gene encoding the melatonin (Mel) receptor 1b were associ-
ated with disruption of normal glucose homeostasis [15]. This
finding indicated that Mel deficiency may be involved in nor-
mal glucose homeostasis. Mel is the “hormone of darkness”
that is secreted mainly by the pineal gland, and is an indolea-
mine with the chemical name N-acetyl-5-methoxytryptamine.
Its primary biological function is as an antioxidant, which
protects the cells from toxic, free radical damage [16]. Mel
obtained additional biological functions with the evolution of
animals, including modulating the circadian timing system [17].
Mel has also been implicated in neuroprotective effects in
many CNS diseases, such as stroke, Parkinson’s and Hunting-
ton’s disease [18–20]. More recently, Mel was shown to pre-
vent neural tube defects in the offspring of diabetic pregnancy
by inhibiting the cellular process of apoptosis [7]. However,
the effect of Mel on autophagy in NSCs exposed to hyperglyce-
mia (HG) has not been widely investigated.
This study aimed to explore the role of autophagy in NSCs
exposed to HG and Mel as a putative neuroprotective agent
in vitro and in vivo. HG damaged NSCs proliferation and
enhanced premature differentiation of NSCs into neurons and
astrocytes. Mel prevented HG effects on NSCs in proliferation
and differentiation though inhibition of autophagy, and the
mTOR signaling participated in this process. Furthermore, inhi-
bition of NSCs autophagy by 3-Ma assisted Mel to modulate
differentiation. Interestingly, increasing NSCs autophagy by
Rapa shows that Mel affects and retards NSCs differentiation.
Taken together, this work indicates that Mel could be used as
a potential drug in the clinical management of GDM patients
to promote fetal CNS development.
MATERIALS AND METHODS
Ethics Statement
All procedures were performed in accordance with the Inter-
national Guiding Principles for Animal Research, as stipulated
by the World Health Organization (1985) and adopted by the
Laboratory Animal Center at Shandong University.
Chemicals
Melatonin, 3-methyladenine, rapamycin, poly-L-lysine hydro-
bromide (PLL), D-(+) glucose and streptozocin were purchased
from Sigma–Aldrich (St. Louis, MO).
Cell Culture
NSCs were prepared from the cerebral cortex of Kunming
mice (obtained from the Animal Resource Center, University
of Shandong, Jinan, China) at embryonic day 12.5 (E12.5) as
previously described [20]. Briefly, we separated the telencepha-
lons from E12.5 mice. Brain tissues were dissected and mechani-
cally dissociated in the serum-free neurosphere culture medium
DMEM: F12 (1:1; Gibco, Gaithersburg, MD). For proliferation, the
proliferation medium was supplemented with 20 ng/ml basic
fibroblast growth factor (bFGF; R&D; Minneapolis, MN), 2% B27
(Gibco), 100 U/ml penicillin, 100 μg/ml streptomycin, and
250 ng/ml amphotericin B. NSCs were incubated at 37C in a
humidified atmosphere of 5% CO2 and 95% air. NSCs were cul-
tured was performed overnight and the culture bottles were
changed to purify the primary cells on the second day. After
3 days, the cells proliferated and formed primary neurospheres
(approximately 30–50 μm in diameter). Neurospheres were
harvested by centrifugation, and dissociated mechanically into
small neurospheres and single cells, which were replated in
the medium.
To examine the proliferation of NSCs, the dissociated NSCs
were cultured in proliferation medium. For differentiation of
NSCs, neurospheres were transferred into differentiation medium,
containing 2% fetal bovine serum (FBS, Gibco) without bFGF
and B27.
Cell Viability Assays
Indirect counting of viable cells was performed with the Cell
Counting Kit-8 (CCK-8; Dojindo; Kumamoto, Japan) assay. NSCs
were seeded into 96-well culture plates (Corning; Oneonta, NY)
at an optimal density of 5–8 × 104 cells per milliliter in 150 μl
of proliferation culture medium per well, and were cultured
overnight. Then culture medium was changed, and reagents
were added to examine NSCs response. After 24 hours, the
medium was replaced by the medium (100 μl) containing CCK-8
reagent (10 μl). NSCs were incubated at 37C for 4 hours. The
optical density of each sample was then measured in a multi-
well spectrophotometer at 450 nm referenced to a wavelength
of 630 nm. Experiments were performed in quadruplicate.
www.StemCells.com ©AlphaMed Press 2019
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5-Ethynyl-20-Deoxyuridine Labeling and
Immunostaining
Cell proliferation was measured using the 5-ethynyl-20-deoxyuridine
(EdU; Guangzhou Ribobio, Co.; Guangzhou, Guangdong, China)
assay. NSCs were seeded into the 96-well plates overnight and
were treated with Mel, 3-Ma or Rapa for 24 hours. EdU (50 μM)
was added, and cells were incubated for 4 hours. Cells were
fixed in 4% paraformaldehyde (PFA) for 20 minutes and permea-
bilized with 0.3% Triton X-100 for 20 minutes. Cells were incu-
bated with the Apollo reaction medium, a reaction cocktail
containing buffer, Alexa Fluor azide and CuSO4, for 30 minutes at
room temperature. The Apollo reaction mixture was removed,
and cells were rinsed once with phosphate-buffered saline (PBS)
for 5 minutes. Hoechst33342 were added for 30 minutes to high-
light nuclei. The cells were rinsed with PBS. The assay was per-
formed according to the manufacturer’s instructions. Images
were obtained under fluorescence microscopy.
Immunocytochemistry
NSCs were plated on coverslips in 24-well plates (15 × 104 cells
per well) coated with PLL. After Mel, 3-Ma or Rapa treatments,
the medium was removed. Cells were fixed in 4% PFA for
20 minutes and rinsed with PBS. The cells were permeabilized
with 0.3% Triton X-100 for 20 minutes at room temperature.
Subsequently, cells were blocked with 3% FBS for 30 minutes,
and incubated with primary antibodies at 4C overnight: anti-Ki
67 (1:100, rabbit polyclonal; Abcam; Cambridge, MA), anti-LC3B
(1:100, rabbit polyclonal; Cell Signaling Technology; Beverly,
MA), anti-Map2 (1:100, rabbit polyclonal; Boster; Wuhan, Hubei,
China), and anti-GFAP (1:100, mouse polyclonal; Boster). The
second antibodies (1:100, DyLight 488 or 594 conjugated goat
anti-mouse or rabbit IgG [H+L]; Abbkine) were incubated with
the cells for 1 hour, and nuclei were counterstained with 40,60-
diamidino-2-phenylindole (DAPI; Boster). Images were obtained
and analyzed using fluorescence microscopy (IX71; Olympus;
Tokyo, Japan).
Western Blotting Analysis
Western blotting was performed as described previously [7, 20].
Protein concentrations were assayed colorimetrically. Proteins
were loaded onto a 10% or 15% gradient polyacrylamide gel,
and electrophoretically transferred to a polyvinylidene difluoride
membrane. Membranes were blocked with 5% dried milk and
subsequently incubated with primary antibody overnight. The
following antibodies were used: p-S6k, S6k, LC3B (1:1,000; rabbit
polyclonal; Cell Signaling Technology), Beclin-1 (1:1,000; rabbit
polyclonal; Boster), and β-actin (1:1,000; mouse monoclonal;
Boster). Secondary antibodies were horseradish peroxidase con-
jugated to goat anti-rabbit IgG or anti-mouse IgG (1:5,000;
mouse monoclonal; Boster). Secondary antibodies were incu-
bated with membrane for 1 hour at 37C.The immunoreactive
bands were visualized by the ECL detection kit (Millipore;
Burlington, MA). The intensity of the bands was quantified
with the Image Processing and Analysis in Java software
(ImageJ, Media, and NIH).
RNA Extraction and Real-Time PCR
Total RNA was isolated from NSCs (1 × 106 cells) using the TRIZOL
(Invitrogen, Carlsbad, CA) method. RNA was reverse transcribed
and purified using the PrimeScript RT reagent Kit with gDNA
Eraser (Takara; Kusatsu, Shiga, Japan). The PCR primers used were
the following: Map2 mouse forward, 50-TCCTTCCCTATAAGTCT
GG-30; reverse, 50-GCATCTCAACCTCGGCTA-30; GFAP mouse for-
ward, 50-CTACATCGAGAAGGTCCGCT-30; reverse, 50-CCTGTGCAAA
GTTGTCCCTC-30 and β-actin primer: forward, 50-AGATGTGGATCA
GCAAGCAG-30; reverse, 50-GCGCAAGTTAGGTTTTGTCA-30. RT-PCR
for Map2, GFAP, and β-actin were performed using the SYBR Pre-
mix Ex Taq (Takara). All processes were performed according to
the manufacturer instructions.
Ultrastructure Analysis with Transmission Electron
Microscopy
A transmission electron microscope (TEM) was used for ultra-
structural analysis of NSCs and brain tissues. Briefly, NSCs or
fresh brain tissues were fixed with 3% glutaraldehyde at 4C
for 24 hours. After fixation, tissue or NSCs were rinsed twice in
PBS immediately, postfixed in 1% osmium tetroxide, and then
dehydrated in a graded ethanol series. After dehydration, tis-
sue was embedded in EPON (EMS, Fort Washington, PA).
Ultrathin sections (50 nm) were cut with an ultramicrotome
(Leica UC-6, Leica Microsystems, Nussloch, Germany), stained
with uranyl acetate and lead citrate, and examined via TEM
(JEM-1200EX, JEOL Transmission Electron Microscope, Tokyo,
Japan) at an accelerating voltage of 80 kV.
Mouse Experiments
Kunming mice (8 weeks old) were randomly divided into 3
groups, containing 8 mice per group. Diabetes mellitus mice
were induced by intraperitoneal (i.p.) injection of streptozoto-
cin (STZ, 75 mg/kg) for 3 consecutive days. After 5 days, mice
with blood glucose levels exceeding 16.7 mM (300 mg/dl)
were defined as diabetic mice. Female mice were fertilized
with healthy male Kunming mice in one cage. The emergence
of a copulation plug was designated as embryonic day E0.5.
Pregnant mice were given 10 mg/kg Mel (dissolved in ethanol,
and diluted with Saline) until sacrificed. Mice from the control
(Con) and HG groups were injected with DMSO and saline in
the same manner. All mice were maintained under the same
breeding conditions. At E11.5 and 17.5 embryos were collected
by cesarean section. Three to five babies were randomly cho-
sen from for further testing, and only 1 baby was chosen from
same dam for same testing. The brains of the embryos were
fixed in 4% PFA in PBS at 4C overnight and dehydrated with
20% and 30% sucrose in PFA. Brains were sections (6 μm) using
a Cryostat Microtome (Leica CM 3050; Leica Microsystems,
Nussloch, Germany).
Statistical Analysis
Data are presented as the mean  SD for continuous variables
and as numbers or percentages for categorical variables. Statis-
tical significance was determined using the t test in 2 groups,
and one-way analysis of variance was performed to compare
data (for ≥3 groups), using Dunnett’s multiple comparison post
hoc test. A p value <.05 was considered to be significant. All
the data analysis and expression was performed using Statisti-
cal Package for the Social Sciences 20.0 for Windows (SPSS,
Inc.; Chicago, IL) and Graphpad Prism7.0 (GraphPad Software;
La Jolla; CA).
©AlphaMed Press 2019 STEM CELLS
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RESULTS
Increased Autophagy Mediates Reduced Viability of
NSC in HG
NSCs were cultured in the medium with increasing concentra-
tions of D-(+)-glucose (15, 25, 35, 45, and 55 mM). The NSCs
viability was assessed by CCK-8 assay. The results showed that
treatment with increasing concentrations of glucose for 24 hours
repressed the cell viability in a dose-dependent manner (Fig. 1A).
When concentration of glucose was over 35 mM, it exhibited
decreased cell viability.
We then examined whether HG might stimulate autophagy
in NSCs. Protein lysates were prepared from NSCs treated with
increasing concentrations of glucose (25–45 mM), and protein
marker for autophagy, LC3B and Beclin-1, were examined by
Western blot (Fig. 1B). The ratio of LC3B II/I did not change
significantly in NSCs under varying HG conditions (Fig. 1C).
However, Beclin-1 protein levels were significantly increased
and p62 was decreased (Supporting Information), indicating
that autophagy might be enhanced (Fig. 1D). Therefore, we
further investigated the LC3B II/I ratio by treating NSCs with
inhibitors of autophagic flux. NSCs were first treated with the
H+-ATPase inhibitor, Bafilomycin A1 (BAF A1, 100 nM) which
blocks fusion of autophagosomes and lysosomes, and thus
inhibited degradation of LC3B II by the lysosomal enzymes
[21]. However, in our system, BAF A1 did not efficiently block
autophagic flux. Thus, we used a second lysosomotropic agent,
NH4Cl, which penetrates acidic compartments and raises the
pH in lysosomes to inhibit lysosomal degradation of the LC3B
II [21–23]. NSCs were treated with 10 mM NH4Cl for 4 hours
before collecting samples. Importantly, the concentration of
NH4Cl at 10 mM did not change medium pH to disturb cellular
Figure 1. Increased autophagy mediates reduced viability of neural stem cell (NSC) in hyperglycemia. (A): NSCs were treated with differ-
ent concentrations of D-glucose for 24 hours, and cell viability was determined by CCK-8 assay. (B): Western blotting analysis showed LC
3B and Beclin-1 expression in NSCs exposed to different concentrations of glucose for 24 hours. The second LC 3B was detected under
the same conditions, with 4 hours NH4
+ treatment before collecting the protein samples. (C–E): Column graphs show the Western blotting
results, the ratio between LC 3B II and LC 3B I, and Beclin-1 protein expression. Values are compared with con. (F): The viabilities of NSCs
were treated with autophagy inhibitor and inducer in HG for 24 hours. Values were compared with hyperglycemia (HG). All experiments
were performed three times, and the bulbs represent the results from each experiment. Values are mean  SD. *, p < .05; **, p < .01;
***, p < .001; ****, p < .0001.
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metabolism. The Western blotting results revealed that a trend
for an increasing LC3B II/I ratio was observed in HG-treated
NSCs exposed to NH4Cl (Fig. 1E). These results suggested that
autophagic flux, from the process of phagophore formation to
fusion with lysosmal system and degradation, was enhanced
when cells were incubated under HG conditions.
Next, we assessed the role of NSCs autophagy in HG
(35 mM). To test this, we used the autophagic inhibitor (3-Ma)
or the autophagic inducer (Rapa) to treat NSCs under HG con-
ditions. The results showed that inhibiting autophagy by 3-Ma
(2 and 4 mM) significantly promoted cell viability and inducing
autophagy by Rapa (50 and 100 nM) exhibited opposite results,
suggested that decreased NSCs viability in HG was due to
increased autophagy (Fig. 1F). Furthermore, 35 mM D-glucose,
2 mM 3-Ma and 50 nM Rapa were sufficient to yield the appro-
priate response in NSCs. These concentrations of these reagents
were therefore applied to NSCs in subsequent experiments
unless otherwise stated.
Melatonin Enhances NSCs Viability in HG
We next investigated the viability of NSCs in 35 mM HG after
exposure to various concentrations of Mel (10 nM, 100 nM,
1 μM, and 10 μM). Cell viability was enhanced in the presence
of Mel at dosage ranges from 10 nM to 1 μM, but further
reduced at Mel concentrations >1 μM (Fig. 2A). Because 100 nM
Mel yielded the optimal effects of cell viability (Fig. 2A), we used
this concentration in subsequent experiments unless otherwise
stated.
Mel Inhibits Autophagy of NSCs in HG
Mel has been shown to both promote and inhibit autophagy,
but the effects are dependent on different cell types and dif-
ferent pathologies [24–28]. To determine the influence of Mel
on autophagy in NSCs, the expression levels of LC3B, Beclin-1,
and mTOR signaling downstream substance p-S6k were exam-
ined. A significant LC3B result could not be detected in HG, so
NH4Cl was added to block autophagic flux. The results showed
that HG improved LC3B II/I ratio and Mel counteracted upre-
gulation of LC3B II/I ratio (Fig. 2B, 2C). HG markedly increased
the level of Beclin-1 and reduced p-S6k in NSCs. Under HG
condition, in the presence of Mel, autophagy appeared to be
attenuated in NSCs, because Beclin-1 was reduced and p-S6k
was increased (Fig. 2B, 2D, 2E). The autophagy activator Rapa
inhibited the effect of Mel on NSCs; p-S6k expression was
reduced (Fig. 2B, 2E). Finally, the autophagy inhibitor 3-Ma
enhanced the effect of the hormone on NSC; the level of p-S6K
was increased in HG.
Immunocytochemistry was used to confirm the results for
LC3B. For these experiments, cells were treated as indicated
for 24 hours followed by exposure to NH4Cl for 4 hours before
fixation of cells for immunocytochemistry. Consistent with the
Western blotting results, the immunofluorescence analysis of
LC3B showed that HG increased the number of LC3B-positive
cells and Mel blocked HG-mediated effects. Rapa inhibited the
Mel effects and led to the greatest number of LC3B-positive
cells and 3-Ma supplement assisted Mel effects and decreased
LC3B-positive cells (Fig. 2F, 2G).
Finally, we used transmission electron microscopy, the gold
standard for monitoring autophagy, to confirm autophagy in
NSCs. HG induced autophagosomes and mitochondrial swelling
in NSCs. Mel antagonized these changes in NSCs; the number
of autophagosomes was decreased and the morphology of
mitochondrial body remained normal (Fig. 2H, 2I). All together,
these results suggested that Mel inhibited autophagy in NSCs
in HG conditions.
Melatonin Promotes NSCs Proliferation and
Self-Renewal of NSCs in HG
To assess the effect of Mel on cell proliferation, we performed
EdU staining. HG led to decreased proliferation relative to the
Con, and Mel could obviously promote cell proliferation in HG
(Fig. 3A). Furthermore, inhibiting autophagy by 3-Ma together
with Mel in HG contributed to cell proliferation, and increasing
autophagy by Rapa inhibited the Mel protective effects.
We next performed the neurosphere formation test, neu-
rospheres formed under all culture conditions, there were
measurable differences in the size and the numbers of the
spheres formed. The number of neurospheres formed was
reduced in HG-treated group relative to Con group (Fig. 3B).
More importantly, Mel supplementation opposed HG-mediated
effects (Fig. 3B). Consistently, increasing autophagy by Rapa
blocked Mel effect on neurospheres formation. On the con-
trary, inhibition of autophagy by 3-Ma assisted Mel effect on
neurospheres formation (Fig. 3B). Specifically, the diameters of
spheres were larger in the Mel group relative to the HG group,
and addition of the autophagy inhibitor 3-Ma led to further
increases in the diameter of these spheres. However, this dif-
ference between Mel group and 3-Ma group was not statisti-
cally significant. In contrast, addition of the autophagy activator
Rapa decreased the diameter of spheres (Fig. 3B).
These results indicated that Mel could protect NSCs prolif-
eration and self-renew abilities from HG through inhibition of
autophagy.
Melatonin Inhibits Premature Differentiation of
NSCs in HG
For cell differentiation analysis, we assessed protein and mRNA
levels of astrocyte marker GFAP and neuron marker Map2 using
qPCR and immunocytochemistry at 5 days. The number of
Map2-positive and GFAP-positive cells increased in the HG group
compared to that in the Con group, indicating that HG triggered
NSCs premature differentiation. More importantly, HG-induced
premature differentiation could be diminished by Mel (Fig. 4A, 4B).
Interestingly, the autophagy inducer Rapa as well as 3-Ma led to
suppression of Map2- and GFAP-positive cells among HG-treated
NSCs in the presence of Mel (Fig. 4A, 4B). RNA levels of Map2 and
GFAP were increased in HG compared with Con (Fig. 4C). However,
Map2 and GFAP mRNAs did not increase over controls under HG
treatment in the presence of Mel. Again, Map2 and GFAP were
suppressed in NSC under HG treatment by Rapa as well as 3-Ma in
the presence of Mel (Fig. 4C). In fact, Rapa treatment led to signifi-
cantly decreased Map2 and GFAP mRNA levels compared to con-
trols (Fig. 4C). Thus, increased autophagy induced by Rapa may
impair differentiation of NSCs. Taken together, Mel shows good
potential to diminish premature differentiation of neurons and
astrocytes, and mimicked the NSCs differentiation under normal
condition.
Melatonin Antagonizes HG In Vivo
Mice were randomly divided into 3 groups, Con, HG and Mel
treatment groups. Fasting blood glucose levels were not
©AlphaMed Press 2019 STEM CELLS
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significantly different among groups (Con 4.45  0.9, HG
4.57  0.87, and Mel 4.53  0.76 mM). Diabetes mellitus was
induced in mice in HG and Mel groups though treatment with
STZ. The mice in the Mel group were treated with Mel every
day (10 mg/kg intraperitoneal injection) from the day they
were mated to the day of sacrifice. And Mel group showed no
difference in random blood glucose levels compared with HG
group (Con 6.3  1.2, HG 18.4  3.4, and Mel 17.5  4.1 mM;
Fig. 5A).
We chose 11.5 days pregnant mice to stain brain slices with
Ki67 and LC3B. The HG group had fewer Ki67-positive cells than
the Con group, indicating that HG suppressed cell proliferation.
Mel supplement markedly diminished HG-mediated inhibition of
cell proliferation by increasing Ki67-positive cells (Fig. 5B, 5C). In
regard to cell autophagy analysis, More LC3B-positive cells were
detected in brain sections from the HG group than that in the
Con group, which was consistent with increased autophagy in
NSCs in vitro. However, under Mel treatment, the number of
LC3B-positive cells in HG animals was again comparable to
controls (Fig. 5D, 5E).
We next stained E17.5 mice’s brain slices with Map2 and
GFAP to investigate cell differentiation. Because neurogenesis and
gliogenesis reach their peaks before and after birth, respectively,
GDM influences neurogenesis more than gliogenesis [29]. We
focused on the cortical region, which contains mainly neurons.
Here, the HG mice exhibited a significantly greater area of
Map2 expression than controls. However, Mel treatment signifi-
cantly reduced the area of Map2 expression induced by HG
(Fig. 6). Similar results were found for GFAP expression (Fig. 6).
Finally, we used TEM to detect autophagy in brain tissues
from the treated animals. We observed autophagosomes, which
had two parallel membrane bilayers and contained mitochondria,
ribosomes and endoplasmic reticulum (Fig. 7). HG treatment
enhanced the formation of autophagosomes compared to the
Con group, and led to mitochondrial swelling. Such effects were
diminished in the presence of Mel (Fig. 7).
DISCUSSION
Identifying the molecular basis for the association between
GDM and neurological abnormalities in offspring might lead to
improvements in the clinical management of these patients.
Here, we found HG increased autophagic flux and decreased
proliferation of NSCs. Remarkably, Mel promoted viability and
proliferation of NSCs exposed to HG. As it has previously been
Figure 3. Melatonin contributes to proliferation and neurosphere formation. (A): Immunofluorescence images showed 5-ethynyl-
20-deoxyuridine (EdU)-positive cells. And the column graphs represented the percentage of EdU. (B): The numbers and diameters of
neurospheres were measured. Representatives of neurospheres images are shown at the top. The bulbs represent the results from each
experiment. Scale bar represents: 20 μm (×40) .Values are mean  SD. *, p < .05; **, p < .01.
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Figure 4. Melatonin inhibits premature differentiation of neural stem cells (NSCs) in hyperglycemia. (A, B): NSCs were cultured in 2%
FBS with different agents for 5 days. Immunofluorescence images showed the number of Map2 (green) and GFAP (red)-positive cells.
Scale bar: 40 μm (×40). (C): qPCR analysis showed expression of Map2 and GFAP mRNA. The bulbs represent the results from each exper-
iment. Values are mean  SD. *, p < .05; **, p < .01; ***, p < .001; ****, p < .0001.
Figure 5. Melatonin enhanced proliferation and decreased autophagy of neural stem cells (NSCs) in vivo. (A): Illustration of the animal
study profile. (B, C): The neural tubes were stained with Ki67 in the presence or absence of melatonin (10 mg/kg per day) treatment at
E11.5. (D, E): The neural tube was stained by LC 3B. Scale bar: 40 μm (×40). Values are mean  SD. *, p < .05; **, p < .01; ***, p < .001
compared to the hyperglycemia group.
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reported that Mel also prevents NSCs in HG from apoptosis
[7], Mel could protect NSCs from programmed cell death,
including apoptosis and autophagy. Therefore, Mel may be an
ideal drug to use in pregnant women with GDM to prevent
NSCs from death in fetuses.
Recent studies demonstrated that the autophagy related
genes including Ambra 1, Atg5, and Beclin-1 contribute to neu-
rogenesis and differentiation. Autophagy may play an impor-
tant role in the development of NSCs under physiological
condition [12, 30]. NSCs differentiation fate was dependent on
specific pathology as well as autophagic conditions [31–34]
and even on different concentration of Mel [35]. Here, we
found that HG triggered early differentiation of NSCs into
neurons and astrocytes, whereas Mel effectively opposed HG-
mediated differentiation, especially neurogenesis. Neurogen-
esis peaks in the pregnancy period at E14 in mice, whereas
astrocytogenesis occurs at postnatal day (P)-2 and oligoden-
drocytogenesis at P14 [29]. Thus, this is the reason why GDM
mainly influenced neurogenesis and Mel inhibited HG-induced
NSCs differentiation into neuron phenotype in the present
study. Interestingly, Mel with Rapa inhibited the NSCs differen-
tiation in HG, and the results were inconsistent that increasing
autophagy by HG caused NSCs premature differentiation. The
reason for this phenomenon might be the different level of
autophagy induced by HG or Rapa. The further study needed to
be done to explain this phenomenon. Yang et al. have demon-
strated that glucose at a concentration of 20 mM inhibited dif-
ferentiation of embryonic stem cells (E14 mouse ESC line) into
neurons [36]. In contrast, we used 35 mM glucose that led to
premature of NSCs into neurons. Therefore, these opposite
results may be due to different stem cell types used and differ-
ent high glucose concentrations. Accumulation of morphologi-
cally abnormal mitochondria was also detected in NSCs after HG
treatment in vivo and in vitro. Thus, changes in mitochondrial
morphology might be partially responsible for premature differ-
entiation. Khacho et al. discovered that manipulation of the
mitochondrial structure could promote NSCs differentiation by
driving the production of reactive oxygen species (ROS) [37].
Furthermore, Yang et al. showed that a decrease in the level of
glyoxalase 1, a detoxifying enzyme, could induce premature
differentiation of neural precursor cells in GDM mice [38]. Taking
together, premature differentiation of NSCs caused by maternal
diabetes might involve many pathological factors, including abnor-
mal accumulation of mitochondria, HG, ROS, and methylglyoxal.
Several of our results indicated that HG induced autophagy
of NSCs, including increases in the number of autophagosomes
Figure 6. Mel decreased premature differentiation of neural stem cells in vivo. Immunofluorescence image showed double staining of
Map2 (red) and GFAP (green) within the E17.5 cortex of mice. Scale bar: 100 μm (×20). Values are mean  SD. *, p < .05; **, p < .01;
***, p < .001 compared to the HG group.
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observed by TEM and Beclin-1 expression level. Although we ini-
tially observed no stable trend of LC3B expression in NSCs trea-
ted with different dosages of HG, we examined whether this
may be due to the rapid speed of autophagosomes fusion with
lysosomes, which led to more LC3B II degradation. To confirm
this, we firstly blocked autophagic flux by BAF A1. However, BAF
A1 failed in disrupting autophagy flux in our system, possibly
due to insufficient penetration of drug into neurospheres. There-
fore, we replaced BAF A1 with NH4Cl, a lysosome inhibitor, to
interrupt autophagic flux. We used 10 mM in our study, and a
concentration of NH4Cl less than 250 mM could not inhibit lyso-
somal function and change the medium pH [22]. In the presence
of NH4Cl, the ratio of LC3B II/I tended to increase in HG-treated
NSCs. However, a recent study reported that HG inhibited E10.5
brain autophagy in vivo [39]. Our explanation for this discrep-
ancy is as following: (a) we used NSCs mainly at E11.5 and (b) we
examined the relationship between autophagy and HG in vitro and
autophagic flux could be easily blocked, but autophagic flux was
hardly blocked in vivo. The discrepancy was probably related to
autophagy flux interference. Because of the sensitivity of NSCs to
autophagy, more study methods need to be used to estimate the
relationship between stress and autophagy. Studies have also
reported that HG contributes to autophagy in retinal cells and pla-
centa [40, 41]. However, HG has also been shown to impair autop-
hagy in endothelial progenitor cells and umbilical vein endothelial
cells [42, 43]. These different results indicate that modulation of
autophagy is complex and possibly dependent on the tissues and
the pathologic conditions.
Dysregulation of mTOR signaling underlies various brain
developmental disorders, such as autism, dyslexia, epilepsy,
ADHD, and mental retardation [8]. Therefore, we investigated
this pathway as a potential mediator of Mel activity in NSCs.
In fact, mTOR has been shown to regulated stem cells func-
tions. Furthermore, activating mTOR signaling has been shown
to contribute to proliferation of neural progenitor cells and
enhance neurogenesis in aging mice [44]. In undifferentiated
embryonic stem cells, p70S6k activity is maintained at low
levels. Once the cells begin to differentiate, mTORC1 and
p70S6K mediate protein translation increased [13]. Indeed, we
demonstrated that Mel decreased autophagy by activating
mTOR signaling. Interestingly, although both HG and Rapa
treatment decreased mTOR activity, these treatments elicited
different effects on differentiation. HG caused premature
differentiation of NSCs, while Rapa treatment led to retard
of differentiation. Different level of mTOR inhibition may be
responsible for these differences. Thus, Mel might decrease
neurogenesis and gliogenesis by activating the mTOR pathway,
which could mimic the normal NSCs differentiation.
CONCLUSION
We discovered HG reduced viability and induced premature
differentiation of NSCs by increasing autophagy. However,
the hormone Mel suppressed HG-induced autophagy thereby
promoting NSCs proliferation and self-renewal of NSCs. In addi-
tion, NSCs were treated with Mel could diminish premature
Figure 7. Ultrastructure of autophagy in brain tissues. Transmission electron microscopy images showed the autophagosomes and swell-
ing mitochondria. Column chart showed the quantity of autophagosomes per field. Values are mean  SD. *, p < .05; **, p < .01;
***, p < .001 compared to the HG group. Scale bar: 2 μm (×7,500).
www.StemCells.com ©AlphaMed Press 2019
Li, Zhang, Liu et al. 513
differentiation and mimic the normal NSCs differentiation in
HG. Thus, Mel is potentially an ideal supplement for GDM
patients to prevent fetal neurodevelopment diseases.
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